Instem plc Director/PDMR Shareholding (7011O)
11 Octubre 2021 - 09:15AM
UK Regulatory
TIDMINS
RNS Number : 7011O
Instem plc
11 October 2021
Instem plc
("Instem" or the "Company")
Director/PDMR Dealings
Instem (AIM: INS.L), a leading provider of IT solutions to the
global life sciences market, has been notified that, on 11 October
2021, Nigel Goldsmith, Chief Financial Officer, acquired 2,500
ordinary shares in the Company at a price of 825p per share.
Following this acquisition, Mr. Goldsmith is interested in 2,500
ordinary shares, representing 0.01 per cent. of the ordinary shares
in issue.
For further information, please contact:
Instem plc via Walbrook
Phil Reason, CEO
Nigel Goldsmith, CFO
Singer Capital Markets (Nominated Adviser
& Broker) +44 (0) 20 7496 3000
Peter Steel
Rachel Hayes
Alex Bond
Walbrook Financial PR +44 (0) 20 7933 8780
Tom Cooper instem@walbrookpr.com
Nick Rome
About Instem
Instem is a leading provider of IT solutions & services to
the life sciences market delivering compelling solutions for Study
Management and Data Collection; Regulatory Solutions for
Submissions and Compliance; and Informatics-based Insight
Generation.
Instem solutions are in use by over 700 customers worldwide,
including all the largest 25 pharmaceutical companies, enabling
clients to bring life enhancing products to market faster. Instem's
portfolio of software solutions increases client productivity by
automating study-related processes while offering the unique
ability to generate new knowledge through the extraction and
harmonisation of actionable scientific information.
Instem products and services now address aspects of the entire
drug development value chain, from discovery through to market
launch. Management estimate that over 50% of all drugs on the
market have been through some part of Instem's platform at some
stage of their development.
To learn more about Instem solutions and its mission, please visit www.instem.com .
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
The information set out below is provided in accordance with the
requirements of Article 19(3) of the EU Market Abuse Regulation No
596/2014.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Nigel Goldsmith
--------------------------------------- --------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------
a) Position / status Chief Financial Officer and PDMR
--------------------------------------- --------------------------------------------
b) Initial notification Initial Notification
/ Amendment
--------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------
a) Name Instem plc
--------------------------------------- --------------------------------------------
b) LEI 213800PILYUFNNROQX68
--------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------------------
a) Description of the Ordinary shares of 10 pence each
financial instrument
, type of instrument
GB00B3TQCK30
Identification code
--------------------------------------- --------------------------------------------
b) Nature of the transaction Purchase of ordinary shares
--------------------------------------- --------------------------------------------
c) Price(s) and volume(s) Price Volume
--------------------------------------- ------------------------- -----------------
825 pence 2,500
---------------------------------------------------------------------- -----------------
d) Aggregated information N/A - single transaction
- Aggregated volume
- Price
--------------------------------------- --------------------------------------------
e) Date of the transaction 11/10/2021
--------------------------------------- --------------------------------------------
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
--------------------------------------- --------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBSBDGSBBDGBB
(END) Dow Jones Newswires
October 11, 2021 10:15 ET (14:15 GMT)
Instem (LSE:INS)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Instem (LSE:INS)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024